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Few reports of liver transplantation exist in patients with congenital absence of the portal
vein and pulmonary hypertension. Living donor liver transplantation is usually performed
before exacerbation of pulmonary hypertension. A 7-year-old girl (height: 131.5 cm;
weight: 27.4 kg) with congenital absence of the portal vein was diagnosed with pulmonary
hypertension (mean pulmonary artery pressure 35 mm Hg), and liver transplantation was
planned before exacerbation of pulmonary hypertension. We successfully managed her
hemodynamic parameters using low-dose dopamine and noradrenaline under monitoring
of arterial blood pressure, central venous pressure, cardiac output, and stroke volume
variation. Anesthesia was maintained using air-oxygen-sevoflurane and remifentanil 0.1 to
0.6 mg∙kg-1∙min-1. It is necessary to understand the potential perioperative complications
in such cases and to adopt a multidisciplinary team approach in terms of the timing of
transplantation and readiness to deal with exacerbation of pulmonary hypertension.*Address correspondence to Takashi Matsusaki, Department
of Anesthesiology and Resuscitology, Okayama University
Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.
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matusakik@ybb.ne.jpCONGENITAL absence of the portal vein (CAPV) is atype of portosystemic shunt that can cause hepatic
encephalopathy, hepatopulmonary syndrome, and porto-
pulmonary syndrome [1]. CAPV is classified as portal vein
deficiency (type 1) and hypoplasia (type 2). Type 1 CAPV
requires liver transplantation in cases complicated with
pulmonary hypertension or liver failure. Type 2 cases
require surgical management or catheter embolization of
the shunt.
Only a few reports exist of pediatric liver transplantation
in patients with CAPV with pulmonary hypertension [2e7].
We report here the anesthetic management of living donor
liver transplantation (LDLT) in a 7-year-old girl with CAPV
and pulmonary hypertension.
CASE PRESENTATION
Written informed consent was obtained from the patient and her
parents for publication of this case report and accompanying im-
ages. A 7-year-old girl (height: 131.5 cm, weight: 27.4 kg) had type 1
CAPV. Although she had no positive family history, a congenital
metabolic abnormality test at birth indicated galactosemia, after
which an abdominal computed tomography (CT) scan was per-
formed. She had no mental deterioration and had normal exercise0
rg/10.1016/j.transproceed.2019.11.032tolerance. Our patient was diagnosed with CAPV type 1b, with the
splenic vein serving as the portal vein, flowing into the inferior vena
cava (IVC) without going through the liver (Fig 1A and B); hence,
the patient had no collateral veins and no portal hypertension.
Although the patient did not have any clinical symptoms, persistent
hyperammonemia was conservatively managed by oral lactulose.
Pulmonary hypertension (mean pulmonary artery pressure of 35
mm Hg) was diagnosed by echocardiography at the age of 7 years,
although she did not have any symptoms of dyspnea. Her aspartate
aminotransferase and alanine transaminase were only slightly
elevated, although portal contrast and abdominal CT scan showed
that the native portal vein trunk flowed into infrahepatic IVC as
type 1 CAPV. Cardiac catheterization revealed a mean pulmonary
artery pressure of 35 mm Hg, pulmonary artery resistance of 600
dyne$sec$cm-5, and cardiac index of 2.79 L$min1$m2, leading to a
diagnosis of mild pulmonary hypertension. Since we anticipated
that liver transplantation would be required in the future, our sur-
gical team and pediatric doctors discussed its timing many times.ª 2020 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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PEDIATRIC LIVING DONOR LIVER TRANSPLANTATION 631Finally, based on several case reports showing that performing
transplantation before exacerbation of pulmonary hypertension was
the appropriate treatment strategy, we decided to proceed with the
liver transplantation.
She underwent LDLT using an extended left liver lobe graft from
her mother. In such cases, perioperative issues include the possi-
bility of prolonged drug effects and exacerbation of pulmonary
hypertension [4]. Due to the risk of exacerbation of pulmonary
hypertension at the time of induction of anesthesia and reperfusion,
the required equipment for extracorporeal membrane oxygenation
(ECMO) and nitric oxide inhalation was kept available preopera-
tively, in consultation with the cardiac surgery department. In our
preoperative conference (anesthesiologists and surgical teams), we
determined that in case of circulatory collapse, the cardiac surgical
team would help establish ECMO assistance. Hence, the surgical
team preoperatively performed cannulation of the femoral artery
and vein in order to facilitate rescue ECMO.
General anesthesia was induced without premedication using air-
oxygen-sevoflurane inhalation, with intravenous injection of 50 mg
fentanyl and 20 mg rocuronium to facilitate tracheal intubation.
After induction, 2 other peripheral venous lines and a triple-lumen
central venous line were inserted into the right jugular vein.
Anesthesia was maintained using air-oxygen-sevoflurane and remi-
fentanil 0.1 to 0.6 mg∙kg1∙min-1. Intraoperatively, we monitored
central venous pressure, cardiac output, and stroke volume (Vigileo
monitor; FloTrac system; Edwards Lifesciences, Irvine, Calif,
United States), in addition to standard monitoring. The estimated
blood loss was relatively small during the anhepatic phase, which
lasted for 141 minutes. Low-dose dopamine (1.3-4.6 mg∙kg-1∙min-1)
and noradrenaline (0.01 mg∙kg-1∙min-1) were used for maintenance
of vital signs before reperfusion. With this management, her he-
modynamic parameters could be managed without nitric oxide
inhalation and ECMO during and after reperfusion. Our surgical
team also prepared for cannulation of the femoral and axial veins,
in case veno-venous bypass was needed to prevent circulatory
collapse at the time of IVC cross clamping, although the case was
successfully managed without using veno-venous bypass. As for the
recipient procedure, the native portal vein trunk was originally
isolated from hepatoduodenal ligament and flow into infrahepatic
IVC. The native hepatectomy was completed with preservation of
the inferior vena cava and confluence of portal vein trunk as type 1
CAPV (Fig 2A). In the anhepatic phase, massive hemorrhage from
the perihepatic area was almost completely stanched.Fig 1. Preoperative venous angiography. (A) The intrahepatic portal v
The portal vein flowed into the inferior vena cava without going throuImplantation of the left lobe liver graft was started with recon-
struction of the hepatic vein. The left and middle hepatic vein of the
liver graft was anastomosed to native left and middle hepatic vein by
5-0 prolene running suture as the common channel. Subsequently,
the native portal vein trunk was divided from the IVC with the wall
of vena cava, which led to a large orifice for anastomosis. The native
portal vein was anastomosed to the left portal branch of the liver
graft by 6-0 prolene running suture with no size mismatch of the
venous orifice. After that, the hepatic artery was reconstructed
between the native proper hepatic artery of the recipient and the
left hepatic artery of the graft under surgical loupe, followed by
duct-to-duct biliary anastomosis (Fig 2B).
Intraoperatively, arterial blood gases were monitored every
hour and successfully managed without severe hypoxia, acidosis,
or hypercapnia. Body temperature was maintained between
37.2C and 38.5C using a forced-air warming system. The esti-
mated total blood loss was 290 mL, and fluids administered
included 290 mL of albumin, 520 mL of crystalloids, and 380 mL
of colloids. Surgical duration was 7 hours 16 minutes. The patient
was transferred to the intensive care unit postoperatively without
extubation. Her postoperative course was stable, and she was
extubated the following day. She was discharged from the inten-
sive care unit on postoperative day 14 without acute cellular
rejection or worsening of pulmonary hypertension. Her average
pulmonary artery pressure improved to 26 mm Hg, as seen on
thoracic echocardiography. Her portal vein was finally con-
structed after LDLT after 2 months (Fig 3).DISCUSSION
Between 1973 and 2019, 84 cases of CAPV were reported,
but only 1 of these cases had no clinical symptoms [3]. The
reports included cases with airway and tracheal abnormal-
ities due to Goldenhar syndrome, Costello syndrome, and
stenosis of the trachea, in addition to congenital heart dis-
ease and chromosomal aberrations [4]. Since these condi-
tions are often associated with difficult airways or
intubation, thorough preoperative assessment for identifi-
cation of associated congenital abnormalities is required in
patients with CAPV undergoing surgery under general
anesthesia. However, our patient did not have any otherein was absent, and the splenic vein served as the portal vein. (B)
gh the liver.
Fig 2. (A) After hepatectomy, native portal vein trunk flowing into inferior vena cava (IVC) was completely preserved. Confluence of
portal vein and IVC could work as porto-caval shunt during a hepatic phase. (B) The final view of the reconstruction of hepatic artery
and portal vein.
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difficult airway and difficult tracheal intubation.
There are 13 previous reports of cases of pediatric liver
transplantation for CAPV [5], only 2 of which were per-
formed because of pulmonary hypertension [6,7], as in our
case. The reason for liver transplantation in the 13 previous
reports was biliary atresia in 4 cases, pulmonary hyperten-
sion in 4 cases (2 cases of portopulmonary syndrome and 2
cases similar to ours), portosystemic encephalopathy in 4
cases, and hepatoblastoma in 1 case [5]. In cases withFig 3. Postoperative coronal contrast computed tomography
scan 2 months after living donor liver transplantation. The portal
vein was constructed after living donor liver transplantation.pulmonary hypertension, the timing of liver transplantation
is extremely important in terms of reducing mortality.
Hence, in previous reports, performance of liver trans-
plantation before exacerbation of pulmonary hypertension
was considered appropriate [5e7]. In our case, we believe
that performing liver transplantation before exacerbation of
pulmonary hypertension was one of the factors that facili-
tated good perioperative management.
During general anesthesia in children with pulmonary
hypertension, various factors can lead to exacerbation of
pulmonary hypertension, which requires strict management.
Specific exacerbators of pulmonary hypertension include
hypoxemia, hypercapnia, acidosis, invasive stress, and hy-
pothermia [8]. It is also necessary to monitor and appro-
priately maintain fluid balance and acidebase equilibrium. If
pulmonary vascular resistance is elevated, it should be
lowered by administration of pure oxygen or inhalation of
nitric oxide. At the same time, use of catecholamines, such
as norepinephrine, vasopressin, dobutamine, and milrinone,
should be considered for maintenance of systemic blood
flow, including coronary blood flow. In the unlikely event
that circulatory dynamics fail, it is also important to consult
the surgical and co-medical team to ensure appropriate
measures to save the patient’s life.
Regarding monitoring of pulmonary hypertension in
children, the use of pulmonary artery catheters and trans-
esophageal echocardiography is recommended for cases
with severe pulmonary hypertension and low cardiac func-
tion [9]. However, in our case, surgery was completed un-
eventfully without monitoring of pulmonary artery pressure
and transesophageal echocardiography, suggesting that the
need for invasive monitoring should be tailored for each
case in children without severe pulmonary hypertension.
Since our patient was a child with mild pulmonary hy-
pertension, we decided at the outset not to place a pulmo-
nary artery catheter. Also, since upper gastrointestinal
PEDIATRIC LIVING DONOR LIVER TRANSPLANTATION 633endoscopy was not performed before surgery and esopha-
geal varices could not be ruled out, transesophageal echo-
cardiography was not performed. At our institution, when
performing liver transplantation in children, we attempt to
keep bleeding to a minimum; hence, we perform trans-
esophageal echocardiography only when exacerbation of
pulmonary hypertension during surgery is suspected. In the
current case, however, since both surgeons and anesthesi-
ologists performed adequate management and intervention,
surgery was accomplished without circulatory collapse. Our
experience suggests that the need for invasive monitoring
should be tailored for each case and at each facility.
Appropriate perioperative management in such cases re-
quires an understanding of the potential complications
during the perioperative period and full discussion within
the medical team about the timing of transplantation and
preparation for exacerbation of pulmonary hypertension.
In conclusion, we successfully managed the case of a
7-year-old girl with CAPV and portopulmonary syndrome.
To ensure appropriate perioperative management, it is
necessary to understand the potential perioperative com-
plications in such cases and to adopt a multidisciplinary
team approach in terms of the timing of transplantation and
readiness to deal with exacerbation of pulmonary
hypertension.
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